<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Bone marrow stromal cells (MSCs) administered intravenously are effective in reducing neurological deficits after <z:hpo ids='HP_0001297'>stroke</z:hpo> in the rodent </plain></SENT>
<SENT sid="1" pm="."><plain>These cells appear to selectively migrate and express neural phenotypes in ischemic brain </plain></SENT>
<SENT sid="2" pm="."><plain>To elucidate the mechanisms targeting MSC migration into the ischemic brain, we measured, using a microchemotaxis chamber, the effect of select chemotactic factors and cytokines expressed in injured brain, monocyte chemoattractant protein-1 (<z:chebi fb="17" ids="50099">MCP</z:chebi>-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and interleukin-8 (IL-8), on migration of human bone marrow stromal cells (hMSCs) </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, we investigated whether tissue extracts prepared from rat ischemic brain at various times after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAo) induce migration of hMSCs </plain></SENT>
<SENT sid="4" pm="."><plain>Our data indicate that <z:chebi fb="17" ids="50099">MCP</z:chebi>-1, MIP-1alpha and IL-8 enhance the migration of hMSCs </plain></SENT>
<SENT sid="5" pm="."><plain>Ischemic brain tissue extracts at 24, 48 h and 1 week after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> significantly increase hMSC migration across the membrane compared to non-ischemic tissue (p&lt;0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>These data indicate that hMSCs are targeted by inflammatory chemotactic agents and cytokines and that ischemic brain attracts hMSCs </plain></SENT>
</text></document>